The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis

1. UNAIDS. UNAIDS 2016 Estimates, 2017 [cited 2017 December 27]. Available from: http://aidsinfo.unaids.org/.

2. World Health Organization, Health for the world's adolescents: a second chance in the second decade. Geneva, Switzerland: World Health Organization; 2014 [cited 2017 January 06]. Available from: http://apps.who.int/adolescent/second-decade/files/1612_MNCAH_HWA_Executive_Summary.pdf.

3. Davies MA, Gibb D, Turkova A. Survival of HIV-1 vertically infected children. Curr Opin HIV AIDS. 2016;11(5):455–64. doi: 10.1097/COH.0000000000000303 27716730

4. Judd A, Doerholt K, Tookey PA, Sharland M, Riordan A, Menson E, et al. Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996–2006: planning for teenage and adult care. Clin Infect Dis. 2007;45(7):918–24. doi: 10.1086/521167 17806062

5. Johnson LF, Davies MA, Moultrie H, Sherman GG, Bland RM, Rehle TM, et al. The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis. Pediatr Infect Dis J. 2012;31(5):474–80. doi: 10.1097/INF.0b013e3182456ba2 22189531

6. Lowenthal ED, Bakeera-Kitaka S, Marukutira T, Chapman J, Goldrath K, Ferrand RA. Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges. Lancet Infect Dis. 2014;14(7):627–39. doi: 10.1016/S1473-3099(13)70363-3 24406145

7. Judd A, Chappell E, Doerholt K, Galli L, Giaquinto C, Gibb D, et al. Long-term trends in mortality and AIDS-defining events among perinatally HIV-infeced children across Europe and Thailand. International AIDS Conference; 19 July 2016; Durban, South Africa 2016.

8. Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDS. 2014;28(3):128–35. doi: 10.1089/apc.2013.0345 24601734

9. Salou M, Dagnra AY, Butel C, Vidal N, Serrano L, Takassi E, et al. High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo. J Int AIDS Soc. 2016;19(1):20683. doi: 10.7448/IAS.19.1.20683 27125320

10. Kahana SY, Jenkins RA, Bruce D, Fernandez MI, Hightow-Weidman LB, Bauermeister JA, et al. Structural Determinants of Antiretroviral Therapy Use, HIV Care Attendance, and Viral Suppression among Adolescents and Young Adults Living with HIV. PLoS ONE. 2016;11(4):e0151106. doi: 10.1371/journal.pone.0151106 27035905

11. Maskew M, Bor J, MacLeod W, Carmona S, Sherman G, Fox MP. The youth treatment bulge in South Africa: increasing numbers, inferior outcomes among adolescents on ART. International AIDS Conference; 19 July 2016; Durban, South Africa 2016.

12. Nsanzimana S, Kanters S, Remera E, Forrest JI, Binagwaho A, Condo J, et al. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme. Lancet HIV. 2015;2(5):e208–e15. doi: 10.1016/S2352-3018(15)00024-7 26423003

13. Fish R, Judd A, Jungmann E, O'Leary C, Foster C, Network HIVYP. Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit. HIV Med. 2014;15(4):239–44. doi: 10.1111/hiv.12091 24112550

14. Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, et al. Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. HIV Med. 2016;18:171–80. doi: 10.1111/hiv.12411 27625109

15. Schomaker M, Leroy V, Wolfs T, Technau KG, Renner L, Judd A, et al. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe. Int J Epidemiol. 2016:dyw097. Epub 2016 Jun 24. doi: 10.1093/ije/dyw097 27342220

16. Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, Kitaka SB, et al. Differences in factors associated with initial growth, CD4 and viral load responses to ART in HIV-infected children in Kampala, Uganda and the United Kingdom/Ireland. J Acquir Immune Defic Syndr. 2008;49(4):384–92. doi: 10.1097/QAI.0b013e31818cdef5 18931630

17. Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, et al. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLoS Med. 2014;11(9):e1001718. doi: 10.1371/journal.pmed.1001718 25203931

18. United Nations. Transforming our world: the 2030 agenda for sustainable development 2015 [cited 2017 January 18]. Available from: https://sustainabledevelopment.un.org/post2015/transformingourworld/publication.

19. EuroCoord. HIV Cohorts Data Exchange Protocol 2017 [cited 2017 February 20]. Available from: http://www.hicdep.org/.

20. World Health Organization. WHO Anthro (version 3.2.2, January 2011) 2011 [cited 2017 February 20]. Available from: http://www.who.int/childgrowth/software/en/.

21. World Health Organization. WHO growth standard for school aged children and adolescents (who2007_standard) 2007 [cited 2017 February 20]. Available from: http://www.who.int/entity/growthref/tools/who2007_stata.zip.

22. World Bank. World Bank Analytical Classifications: Country Analytical History 2016 [cited 2016 March 15]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.

23. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389–430. doi: 10.1002/sim.2712 17031868

24. White IR, Royston P, Wood AM. Multiple imputation using chained equations. Stat Med. 2011;30:377–99. doi: 10.1002/sim.4067 21225900

25. Zurcher K, Mooser A, Anderegg N, Tymejczyk O, Couvillon MJ, Nash D, et al. Outcomes of HIV-positive Patients Lost to Follow-up in African Treatment Programs. Trop Med Int Health. 2017;22(4):375–87. doi: 10.1111/tmi.12843 28102610

26. Fatti G, Bock P, Eley B, Mothibi E, Grimwood A. Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: an analysis in four provinces in South Africa, 2004–2009. J Acquir Immune Defic Syndr. 2011;58(3):e60–7. doi: 10.1097/QAI.0b013e3182303c7e 21857355

27. UNAIDS. The Gap Report 2014 [cited 2017 January 18]. Available from: http://www.unaids.org/en/resources/documents/2014/20140716_UNAIDS_gap_report.

28. World Health Organization. Antiretroviral therapy for HIV infection in infants and children. Recommendations for a public health approach: 2010 revision 2010 [cited 2017 January 18]. Available from: http://www.who.int/hiv/pub/paediatric/infants2010/en/.

29. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach—Second edition. Geneva, Switzerland 2016 [cited 2017 January 06]. Available from: http://www.who.int/hiv/pub/arv/arv-2016/en/.

30. Sutcliffe CG, van Dijk JH, Munsanje B, Hamangaba F, Sinywimaanzi P, Thuma PE, et al. Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study. BMC Infect Dis. 2011;11:54. doi: 10.1186/1471-2334-11-54 21362177

31. Laughton B, Cornell M, Grove D, Kidd M, Springer PE, Dobbels E, et al. Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS. 2012;26(13):1685–90. doi: 10.1097/QAD.0b013e328355d0ce 22614886

32. Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H, et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013;382(9904):1555–63. doi: 10.1016/S0140-6736(13)61409-9 24209829

33. Johnson LF, Estill J, Keiser O, Cornell M, Moolla H, Schomaker M, et al. Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention? Am J Epidemiol. 2014;180(12):1208–12. doi: 10.1093/aje/kwu295 25399412

34. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE. 2009;4(6):e5790. doi: 10.1371/journal.pone.0005790 19495419

35. Brinkhof MW, Spycher BD, Yiannoutsos C, Weigel R, Wood R, Messou E, et al. Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. PLoS ONE. 2010;5(11):e14149. doi: 10.1371/journal.pone.0014149 21152392

36. Geng EH, Glidden DV, Emenyonu N, Musinguzi N, Bwana MB, Neilands TB, et al. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Trop Med Int Health. 2010;15 Suppl 1:63–9.

37. Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, Fox MP, et al. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS Med. 2011;8(1):e1000390. doi: 10.1371/journal.pmed.1000390 21267057

38. Ardura-Garcia C, Feldacker C, Tweya H, Chaweza T, Kalulu M, Phiri S, et al. Early tracing of children lost to follow-up from antiretroviral treatment: true outcomes and future risks. J Acquir Immune Defic Syndr. 2015;70(5):e160–e7. doi: 10.1097/QAI.0000000000000772 26218409

39. Koech E, Teasdale CA, Wang C, Fayorsey R, Alwar T, Mukui IN, et al. Characteristics and outcomes of HIV-infected youth and young adolescents enrolled in HIV care in Kenya. AIDS. 2014;28(18):2729–38. doi: 10.1097/QAD.0000000000000473 25493599

40. Ferrand RA, Munaiwa L, Matsekete J, Bandason T, Nathoo K, Ndhlovu CE, et al. Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe. Clin Infect Dis. 2010;51(7):844–51. doi: 10.1086/656361 20804412

41. Pegurri E, Konings E, Crandall B, Haile-Selassie H, Matinhure N, Naamara W, et al. The missed HIV-positive children of Ethiopia. PLoS ONE. 2015;10(4):e0124041. doi: 10.1371/journal.pone.0124041 25879446

42. UNAIDS. Prevention Gap Report 2016 [cited 2017 February 02]. Available from: http://www.unaids.org/sites/default/files/media_asset/2016-prevention-gap-report_en.pdf.